Charité strengthens research on alternatives to animal testing

Animal testing is a common part of research on diseases. Charité – Universitätsmedizin Berlin is now supporting ten new projects, each pursuing one of three aims: using human tissue to…

— LGMD is a Rare Form of Muscular Dystrophy with No Approved Therapy —

Closing follows announcement of acquisition on January 18, 2023 / Acquisition bolsters Bayer’s position in digital medical imaging / Blackford will utilize Bayer’s well established “arm’s length” operating model to preserve the company’s…

Malfunction of cellular condensates is a disease mechanism relevant for congenital malformations, common diseases, and cancer

Researchers from Charité – Universitätsmedizin Berlin, the Max Planck Institute for Molecular Genetics (MPIMG), and the University Hospital Schleswig-Holstein (UKSH) have investigated in detail how BPTA syndrome, an extremely rare hereditary…

The signaling molecules of the immune system should trigger a response only where necessary. To prevent a life-threatening spread to the rest of the body, connective tissue can absorb these molecules like a sponge. A team led by Thomas Blankenstein…

To foster an ecosystem of scientific innovation for the improvement of human health, we are really proud to launch the

1st NUVISAN DRUG DISCOVERY INNOVATION CHALLENGE

The Lausanne University Hospital (CHUV) has reported the initial dosing of a patient in a phase II clinical study investigating the sensitivity of PENTIXAFOR (Boclatixafotide) in a cardiovascular and inflammatory setting. It is the first time that…

Biochemist and physician at the Berlin Institute of Health is conducting research into how our blood form

Combining single-cell data with a self-learning algorithm reveals how structural changes in chromosomes can trigger cancer. This new method could pave the way for personalized cancer treatments, writes a team led by Ashley Sanders in “Nature…